Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Nature Communications|October 19, 2021
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19Britton Boras, Rhys M Jones, Brandon J Anson, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2020
Functional Landscape of SARS-CoV-2 Cellular RestrictionLaura Martin-Sancho, Mary K Lewinski, Lars Pache, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2021
Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Exhaled Aerosols and Efficacy of Masks During Early Mild InfectionOluwasanmi O Adenaiye, Jianyu Lai, P Jacob Bueno de Mesquita, et al.
Biorxiv : the Preprint Server for Biology|February 10, 2021
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccinationMatthew J Gorman, Nita Patel, Mimi Guebre-Xabier, et al.
Cell Host & Microbe|November 19, 2024
A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in miceJames Brett Case, Shilpa Sanapala, Carly Dillen, et al.
NPJ Vaccines|February 14, 2023
Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in miceEtsuro Nanishi, Francesco Borriello, Hyuk-Soo Seo, et al.
Cell Reports. Medicine|September 6, 2021
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccinationMatthew J Gorman, Nita Patel, Mimi Guebre-Xabier, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan James Fritch, Thomas R Lane, et al.
ACS Omega|March 29, 2021
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan J Fritch, Thomas R Lane, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktailJinhui Dong, Seth Zost, Allison Greaney, et al.
Pageof 12